Technical Analysis for XGN - Exagen Inc.

Grade Last Price % Change Price Change
F 12.16 2.01% 0.24
XGN closed up 2.01 percent on Monday, August 2, 2021, on 32 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Aug 9
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical XGN trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction 2.01%
Oversold Stochastic Weakness 2.01%
Lower Bollinger Band Walk Weakness -0.98%
Outside Day Range Expansion -0.98%
Oversold Stochastic Weakness -0.98%
Stochastic Buy Signal Bullish -2.72%
NR7 Range Contraction -2.72%
Older End-of-Day Signals for XGN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Gap Up Closed about 10 hours ago
Fell Below Previous Day's Low about 10 hours ago
Reversed from Up about 10 hours ago
Possible Inside Day about 12 hours ago
Possible NR7 about 12 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Exagen Inc. Description

Exagen Inc. operates as a commercial-stage diagnostics company, develops and markets products for the diagnosis, prognosis, and monitoring of patients affected by autoimmune rheumatic diseases (ARDs). Its lead product includes Avise SLE+CT, a proprietary diagnostic test that provides an enhanced solution for patients with a range of ARDs, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren's syndrome, and scleroderma, as well as other disorders, including fibromyalgia. The company also offers Avise SLE Prognostic, a blood test that complements Avise SLE+CT; Avise MTX, a therapeutic drug monitoring test to measure levels of methotrexate polyglutamates; and Avise HCQ, a blood test for physicians to monitor blood levels of HCQ. In addition, it is developing Anti-TNF, a blood test to monitor the levels of anti-TNF bioactivity in patients with RA; Avise SLE Monitoring, a multi-analyte panel blood test for physicians to track the disease status of their SLE patients; and Avise RA, a blood test to determine bone damage or joint erosion. The company primarily serves rheumatologists in the United States. It was formerly known as Exagen Diagnostics, Inc. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Immunology Disease Bone Autoimmune Diseases Disorders Rheumatoid Arthritis Autoimmunity Blood Test Lupus Rheumatology Fibromyalgia Glutamate Methotrexate Scleroderma Connective Tissue Diseases Erythema Sjögren's Syndrome Systemic Lupus Erythematosus

Is XGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 24.3717
52 Week Low 10.31
Average Volume 58,817
200-Day Moving Average 15.60
50-Day Moving Average 14.30
20-Day Moving Average 13.32
10-Day Moving Average 12.75
Average True Range 0.85
ADX 24.99
+DI 10.62
-DI 23.45
Chandelier Exit (Long, 3 ATRs) 12.82
Chandelier Exit (Short, 3 ATRs) 14.22
Upper Bollinger Bands 14.93
Lower Bollinger Band 11.71
Percent B (%b) 0.14
BandWidth 24.16
MACD Line -0.70
MACD Signal Line -0.58
MACD Histogram -0.1169
Fundamentals Value
Market Cap 153.85 Million
Num Shares 12.7 Million
EPS -293.37
Price-to-Earnings (P/E) Ratio -0.04
Price-to-Sales 4.83
Price-to-Book 4.30
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.20
Resistance 3 (R3) 13.15 12.76 13.02
Resistance 2 (R2) 12.76 12.50 12.78 12.96
Resistance 1 (R1) 12.46 12.33 12.27 12.51 12.91
Pivot Point 12.07 12.07 11.97 12.09 12.07
Support 1 (S1) 11.77 11.81 11.58 11.82 11.41
Support 2 (S2) 11.38 11.64 11.40 11.36
Support 3 (S3) 11.08 11.38 11.30
Support 4 (S4) 11.13